Impedance Cardiology Systems develops cardiovascular monitoring systems for patients with congestive heart failure.
Impedance Cardiology Systems, Inc. engages in biotechnology and is based in Menlo Park, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 29, 2006 | Series B | $5M | 1 | Versant Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | Yes | Series B |